San Diego, California–(Newsfile Corp. – May 10, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) (“Tryp”),…
Category: Tryp Therapeutics
Tryp Therapeutics Partners with Fluence for Psychotherapy Design
San Diego, California–(Newsfile Corp. – May 3, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) (“Tryp”)…
Tryp Therapeutics Announces Q2 2021 Financial Results
San Diego, California–(Newsfile Corp. – April 29, 2021) – Tryp Therapeutics Inc. (CSE: TRYP) (“Tryp” or…
Tryp Therapeutics Reports on Key Milestones for 2021
San Diego, California–(Newsfile Corp. – April 20, 2021) – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)…
Tryp Therapeutics Appoints Greg McKee as Chief Executive Officer
San Diego, California–(Newsfile Corp. – April 1, 2021) – Tryp Therapeutics Inc. (CSE: TRYP) (“Tryp” or…
Tryp Therapeutics Announces Provisional Patent Filing For Improved Administration of Psychedelics
La Jolla, California–(Newsfile Corp. – March 18, 2021) – Tryp Therapeutics (CSE: TRYP), a pharmaceutical company…
Tryp Therapeutics Appoints Luke Hayes as Chief Financial Officer
La Jolla, California–(Newsfile Corp. – March 9, 2021) – Tryp Therapeutics Inc. (CSE: TRYP) (“Tryp” or…
Tryp Therapeutics Reaches Milestone on Psilocybin Drug Manufacturing Program
La Jolla, California–(Newsfile Corp. – February 16, 2021) – Tryp Therapeutics (CSE: TRYP) (“Tryp” or the…
Tryp Therapeutics Appoints Dr. Joel Castellanos as Clinical Advisor
La Jolla, California–(Newsfile Corp. – February 11, 2021) – Tryp Therapeutics (CSE: TRYP) (“Tryp” or the…
Tryp Therapeutics Plans Phase 2a Eating Disorder Clinical Trial with Dr. Jennifer Miller
La Jolla, California–(Newsfile Corp. – February 8, 2021) – Tryp Therapeutics (CSE: TRYP) (“Tryp”), a leading…
Tryp Therapeutics Announces Appointment of Greg McKee as Executive Chairman
La Jolla, California–(Newsfile Corp. – February 3, 2021) – Tryp Therapeutics (CSE: TRYP) (“Tryp”), a leading…
Tryp Therapeutics Appoints Dr. Robin Carhart-Harris to Scientific Advisory Board
La Jolla, California–(Newsfile Corp. – February 2, 2021) – Tryp Therapeutics, a clinical-stage pharmaceutical company developing…